Receptos to Present at Leerink Global Healthcare Conference
GlobeNewswire - Mon Feb 09, 7:06AM CST
Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today announced that Faheem Hasnain, its President and Chief Executive Officer, will be presenting at the Leerink Global Healthcare Conference at the Waldorf Astoria hotel in New York City. The presentation is scheduled as a fireside chat on Thursday, February 12 at 1:25 p.m. Eastern Time.
RCPT: 115.83 (-0.66)
Biotech Stock Mailbag: Arena Pharma, Agenus, EnteroMedics
at The Street - Fri Jan 23, 5:00AM CST
Biotech columnist Adam Feuerstein answers readers' questions about health care.
AGEN: 5.03 (-0.01), ETRM: 1.21 (+0.06), MRK: 58.81 (-0.07), INCY: 75.94 (+0.28), RCPT: 115.83 (-0.66), BMY: 60.04 (+0.56), ARNA: 4.55 (+0.02), NVS: 102.20 (-0.17)
Use Options For A Chance To Buy RCPT At A 45% Discount
at The Street - Tue Jan 20, 10:54AM CST
Looking back to 63 days ago, Receptos, Inc. priced a 3,600,000 share secondary stock offering at $100.00 per share.
RCPT: 115.83 (-0.66)
Jim Cramer's Top Stock Picks: NVAX TGT BMRN RCPT
at The Street - Fri Jan 16, 5:00AM CST
Cramer says Novavax should be on every investor's watch list while Target should have a better 2015 than 2014.
BMRN: 100.76 (+1.98), NVAX: 8.80 (+0.40), TGT: 76.12 (-0.75), RCPT: 115.83 (-0.66)
Today In SA PRO: Thursday, January 15
SA PRO Top Ideas - at Seeking Alpha - Fri Jan 16, 4:00AM CST
Top Idea playing out : LAND (Gladstone Land) by Dane Bowler, December 24, 2014. +10.5% Top Idea playing out : RCPT (Receptos, Inc.) by Stephen Simpson, CFA, August 13, 2013. +585% (See author update » ) New PRO Research: ...
RCPT: 115.83 (-0.66), LAND: 10.68 (+0.18)
Cramer's Mad Money: Go Patriotic (1/15/15)
SA Editor Michael Hopkins - at Seeking Alpha - Thu Jan 15, 11:29PM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday, January 15. The Swiss National Bank surprised investors globally when it cut its currency cap with the euro, sending markets - including those in the...
GPRO: 45.27 (-0.02), FEYE: 42.26 (+2.63), BMRN: 100.76 (+1.98), S: 5.23 (+0.08), NVAX: 8.80 (+0.40), TGT: 76.12 (-0.75), RCPT: 115.83 (-0.66), TWTR: 48.50 (+0.55), MSFT: 43.87 (+0.78), ARRY: 8.05 (+0.08)
Jim Cramer's 'Mad Money' Recap: 5 Reasons Why You Must Buy American Stocks
at The Street - Thu Jan 15, 7:01PM CST
Cramer's new strategy for these turbulent markets is to invest in America first.
FRO: 2.96 (+0.07), NSC: 109.91 (-0.17), LEN: 49.98 (-0.28), BMRN: 100.76 (+1.98), NVAX: 8.80 (+0.40), TGT: 76.12 (-0.75), RCPT: 115.83 (-0.66), JWN: 79.41 (+0.04), CCS: 17.13 (+0.06), CSX: 36.08 (-0.49), MBLY: 36.26 (-0.15)
Receptos Shopping For A Partner With Strong Data In Hand
Stephen Simpson, CFA - at Seeking Alpha - Thu Jan 15, 10:36AM CST
JNJ: 99.62 (+1.18), BIIB: 391.66 (-0.45), RCPT: 115.83 (-0.66), ABBV: 58.05 (+1.00), NVS: 102.20 (-0.17)
Wall Street Breakfast: Oil Majors Cut More Jobs As Crude Slides
Wall Street Breakfast - at Seeking Alpha - Thu Jan 15, 5:30AM CST
AMX: 21.97 (+0.27), BBRY: 10.09 (+0.23), FDO: 77.86 (+0.31), CZR: 10.78 (+0.18), ADBE: 76.51 (+1.92), COUP: 11.06 (-0.07), PBR: 6.98 (+0.44), SPY: 209.78 (+0.86), DLTR: 76.82 (+0.97), QQQ: 106.91 (+0.91), TEF: 15.01 (+0.01), RCPT: 115.83 (-0.66), APA: 67.05 (+2.47), BP: 41.93 (+0.59), DG: 68.82 (+1.23), NYT: 14.45 (+0.28), LAND: 10.68 (+0.18), TRCO: 58.49 (+0.49), AAPL: 127.08 (+0.62)
ALPS Puts Twist On Biotech Investing With Medical Breakthrough ETF
Zacks Funds - Seeking Alpha - Wed Jan 14, 11:48PM CST
Health & Biotech Equities ETFs had an astounding 2014 with the NASDAQ Biotechnology index returning a stellar 34% in 2014 - emerging as the biggest winner among all the sectors. Despite overall valuation concerns in the early phase of the year,...
BBP: 28.36 (+0.12), SBIO: 27.28 (+0.14), BBC: 28.98 (+0.18), SGEN: 31.57 (+0.36), IBB: 323.46 (+3.04), RCPT: 115.83 (-0.66), NPSP: 45.88 (+0.03), XLV: 70.72 (+0.28)
Cramer's Mad Money - Best Biotechs Of 2014 (1/6/15)
SA Editor Miriam Metzinger - at Seeking Alpha - Wed Jan 07, 4:38AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday January 6. Best Biotechs of 2014: Isis Pharmaceuticals (NASDAQ: ISIS ), BioMarin (NASDAQ: BMRN ), OvaScience (NASDAQ: OVAS ), Agios (NASDAQ: AGIO ),...
BLUE: 90.70 (+0.93), GE: 25.15 (+0.26), BMRN: 100.76 (+1.98), OVAS: 44.32 (+0.87), XOM: 93.37 (+1.00), TGTX: 13.13 (-0.19), WFC: 55.33 (+0.47), BA: 149.73 (+1.64), GLUU: 5.12 (+0.14), LUV: 43.30 (-0.20), T: 34.66 (+0.05), TTWO: 28.40 (+0.96), GT: 25.91 (-0.30), SAVE: 79.32 (-0.80), ISIS: 63.86 (-0.43), RNA: 18.65 (unch), IBM: 160.40 (+1.88), AAL: 48.39 (+0.51), MCD: 95.65 (+0.56), RCPT: 115.83 (-0.66), AGI: 5.78 (+0.03), TWTR: 48.50 (+0.55), CVX: 112.78 (+1.92), VZ: 49.31 (-0.21)
Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains
at The Street - Tue Jan 06, 7:25PM CST
The markets are presenting a buying opportunity at current levels, but only if you know which stocks to buy, Cramer says.
TSLA: 203.77 (+0.89), GE: 25.15 (+0.26), OVAS: 44.32 (+0.87), NMM: 12.37 (+0.24), XOM: 93.37 (+1.00), T: 34.66 (+0.05), ESPR: 67.13 (-0.33), IBM: 160.40 (+1.88), IRE: 14.54 (+0.81), DTV: 87.51 (-0.32), PTCT: 53.37 (-0.74), RCPT: 115.83 (-0.66), TEG: 75.56 (-1.61), PPG: 236.77 (+3.74), WAG: 76.05 (-0.49), BLUE: 90.70 (+0.93), TGTX: 13.13 (-0.19), WFC: 55.33 (+0.47), BA: 149.73 (+1.64), RAD: 8.34 (+0.25), ISIS: 63.86 (-0.43), RNA: 18.65 (unch), ACHN: 10.89 (-0.20), JCP: 8.05 (+0.14), CVS: 102.63 (-0.37), MCD: 95.65 (+0.56), AGIO: 118.55 (+0.11), CVX: 112.78 (+1.92), VZ: 49.31 (-0.21), FOLD: 8.36 (-0.11)
The Market's Top 10 Stocks of 2014
Dan Caplinger, The Motley Fool - Motley Fool - Sat Jan 03, 8:00AM CST
For six years now, investors have looked with skepticism at the rise in the stock market. And for a sixth straight year, the markets defied those who were waiting for a major downturn to invest, with the S&P 500 climbing about 14% including...
BLUE: 90.70 (+0.93), TTPH: 35.18 (-0.73), AVNR: 16.96 (unch), SWKS: 81.85 (-0.57), CMRX: 40.16 (+0.08), ACHN: 10.89 (-0.20), HA: 18.72 (-0.31), RCPT: 115.83 (-0.66), PTCT: 53.37 (-0.74), AGIO: 118.55 (+0.11)
Biotech Stocks 2014: The Best, Worst and Fastest-Growing
at The Street - Fri Jan 02, 7:33AM CST
Once again, biotech stocks greatly outperformed the broader market in 2014.
BLUE: 90.70 (+0.93), OVAS: 44.32 (+0.87), ACHN: 10.89 (-0.20), RCPT: 115.83 (-0.66), AGIO: 118.55 (+0.11)
Grab 2015 Gains With These 5 Health Care Trades: Intuitive Surgical, Receptos and More
at The Street - Tue Dec 30, 7:32AM CST
The health care sector is showing strong vitals as we head into 2015. Here's a closer technical look at five health stocks that look ready for breakout gains.
ISRG: 510.73 (+3.02), Q: 63.31 (+0.06), THC: 44.30 (+0.75), RCPT: 115.83 (-0.66), BRKR: 18.77 (-0.02)
Nasdaq stocks posting largest percentage decreases
AP - Tue Dec 23, 5:07PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
MCBK: 20.10 (+0.10), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), OFLX: 31.00 (-0.74), RCPT: 115.83 (-0.66), REXX: 5.08 (+0.13), OTIC: 31.14 (+0.13)
Midday Gainers /Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 23, 11:45AM CST
NICK: 14.91 (unch), JRJC: 5.46 (+0.16), OCN: 9.10 (+0.09), ZAZA: 2.17 (+0.08), VNDA: 12.37 (unch), EPAX: 2.45 (+0.04), FES: 1.19 (+0.06), NQ: 3.95 (-0.03), TECU: 3.07 (-0.02), VRML: 2.08 (+0.12), MYOS: 5.45 (-0.20), PME: 2.42 (-0.07), ESPR: 67.13 (-0.33), ALNY: 95.54 (+1.67), IDSA: 5.82 (-0.08), PRLS: 6.96 (-0.02), ACHN: 10.89 (-0.20), SKYS: 10.55 (-0.65), RCPT: 115.83 (-0.66), AGIO: 118.55 (+0.11)
Receptos (RCPT) Falls Further As It's Water-Logged And Getting Wetter
at The Street - Tue Dec 23, 9:27AM CST
Trade-Ideas LLC identified Receptos (RCPT) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
RCPT: 115.83 (-0.66)
Receptos Initiates SUNBEAM Phase 3 Trial of RPC1063 in Relapsing Multiple Sclerosis
GlobeNewswire - Mon Dec 22, 7:01AM CST
- Following Positive Phase 2 Results, Receptos Now Enrolling Two Phase 3 Trials in Relapsing Multiple Sclerosis -
RCPT: 115.83 (-0.66)